Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.

Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.
复制标题

DOI:
10.1371/journal.pone.0088704
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Inaba M
Inaba M
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Ochi A;Mori K;Emoto M;Nakatani S;Morioka T;Motoyama K;Fukumoto S;Imanishi Y;Koyama H;Ishimura E;Inaba M

文献摘要

参考文献

被引文献

相似文献

胎球蛋白-A是一种在肝脏中合成的循环糖蛋白,与胰岛素抵抗和2型糖尿病有关。然而,胎球蛋白-A合成的调节仍然是模糊的。我们以前报道过吡格列酮治疗能显著降低2型糖尿病患者血清胎球蛋白A水平。为了阐明吡格列酮是否可以直接抑制肝胎球蛋白A的合成,我们研究了吡格列酮对胎球蛋白A表达的影响,在体外和体内。吡格列酮处理抑制Fao肝癌细胞中胎球蛋白-A的mRNA和蛋白表达。有趣的是,罗格列酮而不是二甲双胍也抑制胎球蛋白-A的表达。此外,GW 9662(过氧化物酶体增殖物激活受体(PPAR)γ的抑制剂)逆转了吡格列酮诱导的胎球蛋白A抑制,这表明噻唑烷二酮衍生物可能在胎球蛋白A抑制方面具有共同特征,可能通过PPARγ激活。最后,小鼠经口给予吡格列酮8周导致肝胎球蛋白-A mRNA抑制。这些结果表明,吡格列酮可能通过直接抑制肝脏中胎球蛋白-A的表达而部分改善胰岛素抵抗。
Fetuin-A, a circulating glycoprotein synthesized in the liver, is involved in insulin resistance and type 2 diabetes. However, regulation of fetuin-A synthesis has remained obscure. We previously reported that pioglitazone treatment significantly reduced serum fetuin-A levels in patients with type 2 diabetes. To clarify whether pioglitazone can directory inhibit hepatic fetuin-A synthesis, we investigated the effects of pioglitazone on fetuin-A expression both in vitro and in vivo. Pioglitazone treatment suppressed mRNA and protein expression of fetuin-A in Fao hepatoma cells. Interestingly, rosiglitazone but not metformin, also inhibited fetuin-A expression. In addition, GW 9662, an inhibitor of peroxisome proliferator-activated receptor (PPAR) γ, reversed pioglitazone-induced suppression of fetuin-A, suggesting that thiazolidinedione derivatives may have common characteristics with regard to fetuin-A suppression, possibly through PPARγactivation. Finally, oral administration of pioglitazone to mice for 8 weeks resulted in suppression of hepatic fetuin-A mRNA. These findings suggest that pioglitazone may partially ameliorate insulin resistance through its direct inhibitory effects on fetuin-A expression in the liver.
DOI: 10.2337/db11-1116
发表时间: 2013-02
期刊: Diabetes
影响因子: 7.7
作者:
Monden M;Koyama H;Otsuka Y;Morioka T;Mori K;Shoji T;Mima Y;Motoyama K;Fukumoto S;Shioi A;Emoto M;Yamamoto Y;Yamamoto H;Nishizawa Y;Kurajoh M;Yamamoto T;Inaba M
通讯作者: Inaba M
DOI: 10.2337/db08-0538
发表时间: 2008-10
期刊: DIABETES
影响因子: 7.7
作者:
Stefan, Norbert;Fritsche, Andreas;Weikert, Cornelia;Boeing, Heiner;Joost, Hans-Georg;Haring, Hans-Ulrich;Schulze, Matthias B.
通讯作者: Schulze, Matthias B.
DOI: 10.1074/jbc.m210868200
发表时间: 2003-04-11
影响因子: 4.8
作者:
Heiss, A;DuChesne, A;Jahnen-Dechent, W
通讯作者: Jahnen-Dechent, W
DOI: 10.2337/diacare.29.04.06.dc05-1938
发表时间: 2006-04-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Stefan, N;Hennige, AM;Häring, HU
通讯作者: Häring, HU
DOI: 10.1172/jci200317223
发表时间: 2003-03-01
影响因子: 15.9
作者:
Matsusue, K;Haluzik, M;Gonzalez, FJ
通讯作者: Gonzalez, FJ